Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Clinical Genetics

The Biology and Science of ITPR3 Pathogenic Variants

At a Glance

Immunodeficiency 133 results from pathogenic ITPR3 variants that disrupt calcium release inside cells, weakening T-cell activation. Diagnosis combines genetic testing with immune-cell analysis, while ectodermal features and peripheral neuropathy may also occur.

To understand Immunodeficiency 133, it helps to think of your child’s cells as a house with a complex electrical system. In this condition, the “wiring” that controls calcium—the cellular signal for “action”—is not working correctly. This disruption happens because of a pathogenic variant in the ITPR3 gene [1][2].

The Biology of Calcium Signaling

This is a simplified model of how calcium signaling works. Calcium is not just for bones; inside a cell, it acts like a messenger. When the immune system detects a germ, it needs to send a signal to start fighting.

  1. The Trigger: A T-cell (a type of white blood cell) encounters a germ and sends a signal to the endoplasmic reticulum (ER), which is like a storage tank for calcium [3].
  2. The Gate: The ITPR3 gene provides the instructions for a “gate” called IP3R3 on that tank. Normally, the gate opens to let calcium into the rest of the cell [2][4].
  3. The Backup: When the tank starts to empty, it triggers another process called Store-Operated Calcium Entry (SOCE), which pulls in more calcium from outside the cell to keep the signal strong [2][3].

In children with this condition, the ITPR3 gate is altered. It may be “leaky,” causing the storage tank to stay empty, or it may simply refuse to open. This “blunted” calcium signal means the T-cells may not get the full message to activate, grow, or fight [1][2]. Because calcium is also needed for the development of hair, teeth, and nerves, these systems can be affected too, though the exact connection is still being studied [2][5].

How the Diagnosis is Confirmed

Diagnosing this ultra-rare condition requires specialized laboratory work. You should ensure you have copies of the following two types of reports:

1. The Genetic Report

This test looks at the ITPR3 gene itself. Your report should clearly state:

  • Variant Type: The specific “spelling error” found (e.g., p.Arg2524Cys). The report will state if it is a pathogenic variant, a likely pathogenic variant, or a Variant of Uncertain Significance (VUS) [4].
  • Zygosity: This tells you if the child has one altered copy (heterozygous), two identical altered copies (homozygous), or two different altered copies (compound-heterozygous). Many cases are de novo, meaning the variant happened for the first time in the child and was not inherited from the parents [2][4][1].
  • Transcript Version: A code (like NM_002224.3) that helps doctors identify exactly which part of the gene is being discussed [4].

2. The Immunology Report (Flow Cytometry)

This test counts the different types of immune cells in the blood. In ITPR3 cases, doctors often see:

  • T-cell Lymphopenia: A low total number of T-cells [2][4].
  • Missing “Naïve” Cells: A very low number of “naïve” T-cells (cells that are ready to fight new germs) and a higher-than-normal percentage of “memory” cells (cells that have already fought something) [4].
  • Functional Testing: Some highly specialized or research labs can perform a “calcium flux” test, where they watch in real-time to see if the cells respond correctly to a stimulus. However, this is not available or required for every patient [1][2].

Differentiating from Similar Conditions

Because ectodermal dysplasia (skin/teeth/hair issues) and immunodeficiency often go together, doctors must rule out other conditions that look similar:

Condition Primary Gene Key Differences
Immunodeficiency 133 ITPR3 Often includes peripheral neuropathy (nerve weakness) and a specific T-cell “naïve vs. memory” imbalance [4][2].
NEMO Deficiency IKBKG An X-linked condition affecting males and variably females; often includes a higher risk for specific “atypical” mycobacterial infections [1].
ORAI1/STIM1 Deficiency ORAI1 or STIM1 Impairs the calcium entry (SOCE) and can cause combined immunodeficiency, often with distinct muscle weakness (myopathy) [2].

If your child’s genetic test was “negative” but they have these symptoms, a clinical geneticist may discuss Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS) based on clinical review [2][6].

Common questions in this guide

How do ITPR3 variants cause Immunodeficiency 133?
ITPR3 provides instructions for IP3R3, a calcium-release channel in the endoplasmic reticulum. A disease-causing change can make the channel leaky or unable to open, weakening the calcium signal T cells need to activate, grow, and fight germs. The same signaling pathway may also affect hair, teeth, skin, and peripheral nerves.
What genetic findings support a diagnosis of ITPR3-related Immunodeficiency 133?
A genetic report should identify a pathogenic or likely pathogenic ITPR3 variant and list its exact change, zygosity, and transcript version. Many reported variants are de novo, meaning they arose in the child rather than being inherited from a parent. A variant of uncertain significance does not by itself establish the diagnosis.
What can flow cytometry show in Immunodeficiency 133?
Flow cytometry may show a low total T-cell count, very low numbers of naïve T cells, and a higher proportion of memory T cells. Naïve cells are the part of the immune system prepared to respond to new germs, so this pattern can help doctors understand immune function. Results need to be interpreted with the child’s clinical history and other tests.
Is a calcium flux test required to diagnose ITPR3-related disease?
Calcium flux testing measures how a patient’s cells respond to a stimulus in real time. It may be available through specialized or research laboratories, but it is not available or required for every patient. Genetic findings and immune testing are interpreted alongside the clinical picture.
How is Immunodeficiency 133 distinguished from similar conditions?
Doctors compare the ITPR3 result and immune findings with conditions caused by other genes. IKBKG-related NEMO deficiency is X-linked and may have atypical mycobacterial infections, while ORAI1 or STIM1 deficiency affects calcium entry and can include myopathy. ITPR3-related disease may show peripheral neuropathy and an imbalance between naïve and memory T cells.
What happens if genetic testing does not find an ITPR3 variant?
If the clinical features still suggest this disorder or another genetic condition, a clinical geneticist may review whether broader testing is appropriate. Whole-exome sequencing or whole-genome sequencing may be considered after that clinical review. A negative targeted test does not by itself explain or rule out every possible genetic cause.

Get notified when new evidence is published on immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Disrupted Ca2+ homeostasis and immunodeficiency in patients with functional IP3 receptor subtype 3 defects.

    Neumann J, Van Nieuwenhove E, Terry LE, et al.

    Cellular & molecular immunology 2023; (20(1)):11-25 doi:10.1038/s41423-022-00928-4.

    PMID: 36302985
  2. 2

    Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.

    Blanco E, Camps C, Bahal S, et al.

    The Journal of experimental medicine 2025; (222(1)) doi:10.1084/jem.20220979.

    PMID: 39560673
  3. 3

    A multiple-oscillator mechanism underlies antigen-induced Ca2+ oscillations in Jurkat T-cells.

    Benson JC, Romito O, Abdelnaby AE, et al.

    The Journal of biological chemistry 2023; (299(11)):105310 doi:10.1016/j.jbc.2023.105310.

    PMID: 37778728
  4. 4

    A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease.

    Molitor A, Lederle A, Radosavljevic M, et al.

    Science advances 2024; (10(37)):eado5545 doi:10.1126/sciadv.ado5545.

    PMID: 39270020
  5. 5

    Missense mutations in inositol 1,4,5-trisphosphate receptor type 3 result in leaky Ca2+ channels and activation of store-operated Ca2+ entry.

    Terry LE, Arige V, Neumann J, et al.

    iScience 2022; (25(12)):105523 doi:10.1016/j.isci.2022.105523.

    PMID: 36444295
  6. 6

    [The Great Imposter: Three Cases of Inflammatory Bowel Disease Associated with Innate Immune Defects].

    Hernández DPS, Tamayo SV

    Acta gastroenterologica Latinoamericana 2026; (56(3)):357-364 doi:10.52787/agl.v56i3.597.

    PMID: 42871851

This page explains ITPR3-related Immunodeficiency 133 and genetic and immune testing for informational purposes only and does not constitute medical advice. A clinical geneticist or immunologist should interpret your child’s results and discuss next steps.